Evidence guides
Read past the receptor count.
Guides to mechanism, sleep-apnea evidence, biomarkers and comparative trials, with the studied product and population kept visible.
Guide
Tirzepatide and two receptors: what does the mechanism establish?
Understand GLP-1 and GIP activity without treating a biological explanation as a guarantee of clinical benefit.
Guide
Tirzepatide sleep-apnea evidence: where the approved use begins and ends
Read the actual sleep-apnea population and trial outcome before applying an approval to a microdosing claim.
Guide
Tirzepatide, biomarkers and healthspan: which outcome was actually measured?
Separate a biological signal, disease outcome and broad healthy-aging promise without dismissing meaningful clinical evidence.
Guide
Tirzepatide versus semaglutide: why the trial is not a microdosing winner list
A real head-to-head trial answers a defined weight-management question. Keep its treatments, population and endpoints attached to the result.